EPILEPSIA

Scope & Guideline

Transforming research into clinical excellence.

Introduction

Welcome to your portal for understanding EPILEPSIA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0013-9580
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1909 to 1915, from 1937 to 1950, from 1952 to 1955, 1959, from 1961 to 2024
AbbreviationEPILEPSIA / Epilepsia
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "EPILEPSIA" focuses on advancing the understanding of epilepsy through the dissemination of high-quality research. It encompasses a wide range of topics related to the etiology, diagnosis, treatment, and management of epilepsy, as well as the psychosocial aspects associated with the condition.
  1. Clinical Research and Trials:
    The journal publishes studies on the efficacy and safety of new and existing antiseizure medications, surgical interventions, and other treatment modalities, emphasizing evidence from clinical trials.
  2. Neurophysiology and Biomarkers:
    Research on electroencephalographic (EEG) patterns, biomarkers, and neuroimaging techniques to enhance the understanding of seizure mechanisms and predict surgical outcomes is a significant focus.
  3. Genetics and Epigenetics:
    There is a strong emphasis on the genetic underpinnings of epilepsy, including studies on genetic variants, their phenotypic expressions, and implications for precision medicine.
  4. Pediatric and Adolescent Epilepsy:
    The journal addresses the unique challenges and treatment options for epilepsy in children and adolescents, with a focus on developmental and epileptic encephalopathies.
  5. Psychosocial Aspects and Quality of Life:
    Research exploring the impact of epilepsy on mental health, quality of life, and the social stigma associated with the condition is regularly featured.
  6. Innovative Technologies and Approaches:
    The journal includes studies on the use of wearable devices, artificial intelligence, and telemedicine in the management and monitoring of epilepsy.
The journal "EPILEPSIA" has shown a clear trend towards certain emerging areas of research that reflect the ongoing advancements in the understanding and treatment of epilepsy. These themes are gaining traction as researchers explore innovative approaches and technologies.
  1. Precision Medicine and Genetic Testing:
    There is a growing emphasis on tailored treatment approaches based on genetic testing, with studies investigating the implications of specific genetic variants on treatment efficacy and outcomes.
  2. Wearable Technology and Remote Monitoring:
    Research on the use of wearable devices for seizure detection and monitoring has surged, highlighting the potential for technology to enhance patient care and management.
  3. Neuroinflammation and Immune Mechanisms:
    Emerging studies are focusing on the role of neuroinflammation and immune responses in the pathogenesis of epilepsy, paving the way for novel therapeutic strategies.
  4. Psychogenic Non-Epileptic Seizures (PNES):
    There is an increasing interest in understanding and treating PNES, with a focus on the psychosocial dimensions and interventions that can improve patient outcomes.
  5. Long-Term Outcomes and Quality of Life Studies:
    Research examining the long-term effects of epilepsy treatments on quality of life and psychosocial well-being is gaining prominence, addressing the holistic needs of patients.

Declining or Waning

While "EPILEPSIA" continues to evolve, certain themes have shown a decline in research focus over recent years. These waning areas may reflect shifts in the broader scientific landscape or emerging priorities in epilepsy research.
  1. Generalized Epilepsy Research:
    There has been a noticeable decrease in studies focusing exclusively on generalized epilepsy syndromes, suggesting a shift towards more specific or complex forms of epilepsy.
  2. Traditional Pharmacological Approaches:
    Research centered around older antiseizure medications is declining, possibly due to the increasing interest in novel therapies and personalized medicine.
  3. Surgical Techniques in Established Epilepsy:
    Publications detailing traditional surgical techniques for epilepsy management are less frequent, as the field moves towards innovative and less invasive methods.
  4. Epidemiological Studies:
    Studies focused solely on the epidemiology of epilepsy, without a direct link to treatment outcomes or interventions, appear to be less prominent in recent issues.
  5. Longitudinal Studies without Interventions:
    There is a decrease in longitudinal studies that do not assess interventions or treatment changes, potentially due to a growing emphasis on actionable research.

Similar Journals

Journal of Central Nervous System Disease

Unlocking the mysteries of the central nervous system.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5735Frequency: 1 issue/year

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Current Problems in Pediatric and Adolescent Health Care

Pioneering research for the future of young health.
Publisher: ELSEVIER SCIENCE INCISSN: 1538-5442Frequency: 10 issues/year

Current Problems in Pediatric and Adolescent Health Care is a distinguished peer-reviewed journal published by Elsevier Science Inc, dedicated to advancing the field of pediatric and adolescent health. With an impressive Impact Factor indicative of its relevance—ranking in the 79th percentile in its category and classified in Q2—this journal serves as a vital resource for healthcare professionals, researchers, and students. Covering a wide range of topics from clinical practice to innovative research findings in pediatrics, this scholarly publication is essential for those involved in optimizing health care for children and adolescents. The journal's comprehensive articles and reviews from 1996 to present reflect the evolving landscape of child health, making it a key contributor to evidence-based practice and policy-making in the United States and beyond. While the journal is not open access, readers gain invaluable insights to further their knowledge and improve healthcare outcomes for the younger population.

BRAIN & DEVELOPMENT

Transforming Research into Clinical Insights
Publisher: ELSEVIERISSN: 0387-7604Frequency: 10 issues/year

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

Current Journal of Neurology

Advancing neurology through open dialogue.
Publisher: TEHRAN UNIV MEDICAL SCIENCESISSN: 2717-011XFrequency: 4 issues/year

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Epilepsy & Behavior Reports

Exploring Innovations in Epilepsy Research and Treatment
Publisher: ELSEVIER SCIENCE INCISSN: Frequency: 1 issue/year

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

NEUROLOGICAL RESEARCH

Pioneering Insights in Neurology and Clinical Advances
Publisher: TAYLOR & FRANCIS LTDISSN: 0161-6412Frequency: 12 issues/year

NEUROLOGICAL RESEARCH, published by TAYLOR & FRANCIS LTD, is a distinguished journal focusing on the diverse and evolving field of neurology. Established in 1979, this journal has been a prominent platform for disseminating groundbreaking research and clinical advances up to 2024. With an ISSN of 0161-6412 and an E-ISSN of 1743-1328, it offers valuable insights for researchers, professionals, and students interested in the intricate workings of the nervous system. The journal holds a respectable Q2 ranking in the field of Medicine (miscellaneous) and Q3 in the categories of Neurology and Clinical Neurology, reflecting its commitment to high-quality research. Although NEUROLOGICAL RESEARCH does not currently offer an open access option, its contributions to the literature are vital for fostering advancements in neurological understanding and treatment. With an engaged readership and a mission to advance scientific knowledge, NEUROLOGICAL RESEARCH serves as a crucial resource for anyone dedicated to neurological health and innovation.

Neurologia i Neurochirurgia Polska

Empowering Research, Transforming Practice
Publisher: VIA MEDICAISSN: 0028-3843Frequency: 6 issues/year

Neurologia i Neurochirurgia Polska is a prestigious Polish journal dedicated to advancements in the fields of neurology and neurosurgery, published by VIA MEDICA. With a rich history dating back to 1967, this journal serves as a critical platform for disseminating significant research findings and clinical practices that advance our understanding of neurological disorders and surgical interventions. Registered under ISSN 0028-3843 and E-ISSN 1897-4260, it boasts commendable rankings as reflected in its 2023 categorical quartiles: Q3 in Neurology (Clinical) and Q2 in Surgery, indicating its substantial impact within these domains. Furthermore, its Scopus rankings reveal that it is positioned at Rank #125/551 within Medicine-Surgery and Rank #187/400 in Medicine-Neurology (Clinical), showcasing its importance in academic and clinical circles. Although not currently open access, the journal remains accessible to readers and practitioners who seek to stay updated on innovative research and methodologies. The journal’s objective is to foster knowledge exchange and stimulate scientific dialogue among researchers, professionals, and students, thus shaping the future of neurology and neurosurgery in Poland and beyond. Located at UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND, it invites contributions that inspire and elevate the standards of medical practice.

EPILEPSY & BEHAVIOR

Advancing understanding of epilepsy and its behavioral impacts.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1525-5050Frequency: 12 issues/year

EPILEPSY & BEHAVIOR is a premier journal dedicated to advancing the field of neurology and behavioral neuroscience, published by Academic Press Inc. Elsevier Science. With a focus on the complex interplay between epilepsy and behavioral disorders, this journal serves as a pivotal platform for researchers, clinicians, and educators alike. The journal holds a commendable position with a Q2 ranking in key categories such as Behavioral Neuroscience and Clinical Neurology, highlighting its influence and contributions to the scientific community. Notably, EPILEPSY & BEHAVIOR is indexed in Scopus, ranking in the top percentiles across various related fields, which underscores the quality and relevance of the research it publishes. As it navigates from its inception in 2000 to its ongoing work into 2024, the journal remains committed to disseminating high-quality research and insights that address critical issues in epilepsy and associated behavioral challenges, providing invaluable resources for ongoing education and innovation in the field.

Epilepsia Open

Leading the way in open access epilepsy scholarship.
Publisher: WILEYISSN: Frequency: 4 issues/year

Epilepsia Open is a premier open access journal dedicated to advancing the field of neurology, particularly in the area of epilepsy research and clinical practice. Published by WILEY since 2016, this journal aims to provide a platform for high-quality, peer-reviewed research that fosters collaboration among researchers, clinicians, and educators within the global neurological community. With an impactful presence in the field, it holds a prestigious Q2 ranking in both Neurology and Clinical Neurology categories as of 2023 and has been recognized for its contributions to the understanding of epilepsy through its diverse range of articles, reviews, and clinical studies. Researchers and practitioners can benefit from the journal's open access model, which ensures that valuable findings are readily available to the public, promoting further developments in treatment and care. The journal's significant visibility is reflected in its Scopus rankings, where it ranks in the top half of peer-reviewed journals in both Neurology and Neuroscience categories. For those committed to improving the lives of those affected by epilepsy, Epilepsia Open represents a crucial resource for cutting-edge knowledge and innovative practices.

Progress in Neurology and Psychiatry

Connecting researchers and clinicians for impactful insights.
Publisher: JOHN WILEY & SONS LTDISSN: 1367-7543Frequency: 4 issues/year

Progress in Neurology and Psychiatry is a pivotal journal published by John Wiley & Sons Ltd, dedicated to advancing the fields of neurology and psychiatry. With a robust history dating back to its establishment, this esteemed journal holds a consistent Q3 ranking in 2023 across several categories including Neurology, Clinical Neurology, Psychiatry, and Mental Health, signifying its significant contribution to the scientific community. This journal serves as a vital source of knowledge and insight, publishing original research, reviews, and case studies that explore the intricacies of neurological and psychiatric disorders. Although it does not offer open access, the journal remains accessible to a wide audience through institutional subscriptions. By fostering a platform for scholarly discourse, Progress in Neurology and Psychiatry aims to bridge the gap between research and practice, ultimately enhancing the quality of care for individuals with neurological and psychiatric conditions. Researchers, clinicians, and students are encouraged to engage with the journal's comprehensive content to stay informed of the latest developments and emerging trends in these critical fields of medicine.